Tokio Marine Asset Management Co. Ltd. Grows Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Tokio Marine Asset Management Co. Ltd. lifted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 9.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,078 shares of the company’s stock after buying an additional 834 shares during the period. Tokio Marine Asset Management Co. Ltd.’s holdings in GE HealthCare Technologies were worth $779,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Jennison Associates LLC boosted its stake in shares of GE HealthCare Technologies by 49.4% in the 4th quarter. Jennison Associates LLC now owns 1,208,830 shares of the company’s stock worth $93,467,000 after buying an additional 399,961 shares during the last quarter. South Dakota Investment Council lifted its position in GE HealthCare Technologies by 272.1% during the fourth quarter. South Dakota Investment Council now owns 98,262 shares of the company’s stock valued at $7,598,000 after purchasing an additional 71,857 shares in the last quarter. Cerity Partners LLC lifted its position in shares of GE HealthCare Technologies by 27.2% in the fourth quarter. Cerity Partners LLC now owns 45,929 shares of the company’s stock valued at $3,551,000 after acquiring an additional 9,809 shares in the last quarter. Fifth Third Bancorp lifted its position in shares of GE HealthCare Technologies by 3.9% in the fourth quarter. Fifth Third Bancorp now owns 33,632 shares of the company’s stock valued at $2,600,000 after acquiring an additional 1,250 shares in the last quarter. Finally, Douglas Lane & Associates LLC lifted its position in shares of GE HealthCare Technologies by 22.1% in the fourth quarter. Douglas Lane & Associates LLC now owns 436,253 shares of the company’s stock valued at $33,731,000 after acquiring an additional 79,073 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

GEHC has been the topic of several research analyst reports. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and boosted their price objective for the company from $66.00 to $88.00 in a research report on Monday, February 12th. Evercore ISI boosted their price objective on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. Argus boosted their price objective on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, April 1st. Morgan Stanley boosted their price objective on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research report on Monday, February 12th. Finally, Mizuho lifted their target price on GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, April 11th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $95.09.

GE HealthCare Technologies Trading Up 0.3 %

Shares of NASDAQ GEHC opened at $86.24 on Friday. The business’s 50 day moving average is $88.92 and its two-hundred day moving average is $78.45. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50. The stock has a market capitalization of $39.35 billion, a P/E ratio of 28.56, a PEG ratio of 2.99 and a beta of 0.94.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, beating analysts’ consensus estimates of $1.07 by $0.11. The firm had revenue of $5.20 billion for the quarter, compared to analysts’ expectations of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The company’s quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.31 earnings per share. As a group, research analysts expect that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a dividend of $0.03 per share. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is 3.97%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.